Central Nervous System Stimulants

"Central Nervous System Stimulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.

Descriptor ID	D000697
MeSH Number(s)	D27.505.696.282 D27.505.954.427.220
Concept/Terms	Central Nervous System Stimulants Central Nervous System Stimulants Central Stimulants Stimulants, Central Analeptics Analeptics Analeptic Drugs Drugs, Analeptic Analeptic Agents Agents, Analeptic

Below are MeSH descriptors whose meaning is more general than "Central Nervous System Stimulants".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Central Nervous System Stimulants [D27.505.696.282]
Therapeutic Uses [D27.505.954]
Central Nervous System Agents [D27.505.954.427]
Central Nervous System Stimulants [D27.505.954.427.220]

Below are MeSH descriptors whose meaning is related to "Central Nervous System Stimulants".

Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Stimulants".

Central Nervous System Stimulants
Aphrodisiacs
Appetite Stimulants
Convulsants

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Central Nervous System Stimulants" by people in this website by year, and whether "Central Nervous System Stimulants" was a major or minor topic of these publications.

Bar chart showing 154 publications over 26 distinct years, with a maximum of 15 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	2	0	2
1998	1	0	1
2000	0	2	2
2001	1	0	1
2002	2	1	3
2003	5	2	7
2004	1	0	1
2005	6	1	7
2006	7	2	9
2007	10	5	15
2008	4	3	7
2009	11	3	14
2010	5	1	6
2011	4	2	6
2012	4	1	5
2013	6	3	9
2014	9	2	11
2015	5	2	7
2016	12	0	12
2017	4	2	6
2018	2	1	3
2019	5	1	6
2020	3	2	5
2021	4	0	4
2022	4	0	4
2023	1	0	1

Below are the most recent publications written about "Central Nervous System Stimulants" by people in Profiles.

Bishop JR, Zhou C, Gaedigk A, Krone B, Kittles R, Cook EH, Newcorn JH, Stein MA. Dopamine Transporter and CYP2D6 Gene Relationships with Attention-Deficit/Hyperactivity Disorder Treatment Response in the Methylphenidate and Atomoxetine Crossover Study. J Child Adolesc Psychopharmacol. 2024 Dec; 34(10):458-469.

View in: PubMed
Nakamoto M, Onoye J, Kiyokawa M, Takeshita J, Lu B. Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations. J Addict Med. 2024 Nov-Dec 01; 18(6):657-662.

View in: PubMed
Wiegers E, Garner A, Jusko M, Smith JN, Campez M, Greiner A, Gnagy E, Pelham WE, Raiker J. The Impact of Stimulant Medication on the Relation Between Working Memory and Activity Level in ADHD. Res Child Adolesc Psychopathol. 2024 09; 52(9):1357-1368.

View in: PubMed
Merrill BM, Macphee FL, Burrows-MacLean L, Coles EK, Wymbs BT, Chacko A, Walker K, Wymbs F, Garefino A, Robb Mazzant J, Gnagy EM, Waxmonsky JG, Massetti GM, Waschbusch DA, Fabiano GA, Pelham WE. Single and Combined Effects of Multiple Intensities of Behavioral Modification and Methylphenidate for Children with ADHD in the Home Setting. Res Child Adolesc Psychopathol. 2023 10; 51(10):1481-1495.

View in: PubMed
Anastario M, Firemoon P, Rodriguez AM, Wade C, Prokosch C, Rink E, Wagner E. A Pilot Study of Polysubstance Use Sequences across the Lifespan among Assiniboine and Sioux People Who Use Injection Drugs. Int J Environ Res Public Health. 2022 12 29; 20(1).

View in: PubMed
Pelham WE, Altszuler AR, Merrill BM, Raiker JS, Macphee FL, Ramos M, Gnagy EM, Greiner AR, Coles EK, Connor CM, Lonigan CJ, Burger L, Morrow AS, Zhao X, Swanson JM, Waxmonsky JG, Pelham WE. The effect of stimulant medication on the learning of academic curricula in children with ADHD: A randomized crossover study. J Consult Clin Psychol. 2022 May; 90(5):367-380.

View in: PubMed
Harawa NT, Schrode KM, Daniels J, Javanbakht M, Hotton A, Makgoeng S, Ragsdale A, Schneider J, Fujimoto K, Bolan R, Gorbach P. Factors predicting incarceration history and incidence among?Black and Latino men who have sex with men (MSM)?residing in a major urban center. PLoS One. 2022; 17(3):e0265034.

View in: PubMed
Lee F, Sheeler D, Hotton A, Vecchio ND, Flores R, Fujimoto K, Harawa N, Schneider JA, Khanna AS. Stimulant use interventions may strengthen 'Getting to Zero' HIV elimination initiatives in Illinois: Insights from a modeling study. Int J Drug Policy. 2022 05; 103:103628.

View in: PubMed
Avila JA, Memos N, Aslan A, Andrejewski T, Luine VN, Serrano PA. Voluntary oral methamphetamine increases memory deficits and contextual sensitization during abstinence associated with decreased PKM? and increased ?OR in the hippocampus of female mice. J Psychopharmacol. 2021 Oct; 35(10):1240-1252.

View in: PubMed
Waxmonsky JG, Pelham WE, Baweja R, Hale D, Pelham WE. Predictors of Changes in Height, Weight, and Body Mass Index After Initiation of Central Nervous System Stimulants in Children with Attention Deficit Hyperactivity Disorder. J Pediatr. 2022 02; 241:115-125.e2.

View in: PubMed

People

Explore

Similar Concepts

Top Journals